Premium
Letter: proton pump inhibitor usage still seems to reduce the risk of high‐grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus – authors’ reply
Author(s) -
HvidJensen F.,
Drewes A. M.,
FunchJensen P.
Publication year - 2014
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12931
Subject(s) - medicine , dysplasia , proton pump inhibitor , barrett's oesophagus , population , adenocarcinoma , homogeneous , cancer , environmental health , physics , thermodynamics